Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-hydroxy-4-isopropyl- 2,4,6-cycloheptatriene-1-one
2. 4-isopropyltropolone
3. Beta-thujaplicin
4. Beta-thujaplicin, Sodium Salt
1. Beta-thujaplicin
2. 499-44-5
3. 4-isopropyltropolone
4. Hinokitol
5. Beta-thujaplicine
6. Isopropyltropolone
7. Thujaplicin, Beta
8. Tropolone, 4-isopropyl-
9. .beta.-thujaplicin
10. 2-hydroxy-4-isopropyl-2,4,6-cycloheptatrien-1-one
11. Beta-isopropyltropolon
12. 2,4,6-cycloheptatrien-1-one, 2-hydroxy-4-(1-methylethyl)-
13. Beta-isopropyltropolone
14. .beta.-isopropyltropolon
15. B-thujaplicin
16. 2-hydroxy-4-isopropylcyclohepta-2,4,6-trien-1-one
17. Nsc 18804
18. .beta.-thujaplicine
19. 2-hydroxy-6-propan-2-ylcyclohepta-2,4,6-trien-1-one
20. Nsc18804
21. 2-hydroxy-4-(1-methylethyl)-2,4,6-cycloheptatrien-1-one
22. 2-hydroxy-4-isopropyl-2,4,6-cyclohepta-2,4,6-trien-1-one
23. Chembl48310
24. Mls001048906
25. 2-hydroxy-4-(propan-2-yl)cyclohepta-2,4,6-trien-1-one
26. Hinokitiol 4-isopropyltropolone
27. U5335d6ebi
28. Chebi:10447
29. Nsc-18804
30. Smr000387099
31. 2,4,6-cycloheptatrien-1-one, 2-hydroxy-4-isopropyl-
32. Einecs 207-880-7
33. Brn 2045206
34. Unii-u5335d6ebi
35. Ss-thujaplicine
36. Ai3-28398
37. Beta -thujaplicin
38. Beta -thujaplicine
39. 6-isopropyl-tropolon
40. Thujaplicin, .beta.
41. 2-hydroxy-4-isopropyl- 2,4,6-cycloheptatriene-1-one
42. 4-isopropyl-tropolone
43. Beta -isopropyltropolon
44. Beta-thujaplicin, 99%
45. 4(6)-isopropyltropolone
46. Hinokitiol [inci]
47. Ncimech_000141
48. Cid_3611
49. Hinokitiol [who-dd]
50. Bspbio_001025
51. Kbiogr_000365
52. Kbioss_000365
53. 4-08-00-00488 (beilstein Handbook Reference)
54. Bidd:er0491
55. Schembl158795
56. Spectrum1505160
57. 2-hydroxy-6-isopropyl-cyclohepta-2,4,6-trien-1-one
58. Dtxsid6043911
59. Bdbm79632
60. Fuwuefkexzqkka-uhfffaoysa-
61. Kbio2_000365
62. Kbio2_002933
63. Kbio2_005501
64. Kbio3_000709
65. Kbio3_000710
66. Wln: L7vj Bq Dy1&1
67. .beta.-thujaplicin [mi]
68. Amy3994
69. Bio2_000343
70. Bio2_000823
71. Hms1362c07
72. Hms1792c07
73. Hms1990c07
74. Hms2269d23
75. Hms3403c07
76. Hy-b2230
77. Bbl036671
78. Bdbm50330794
79. Ccg-35378
80. Mfcd00040180
81. S4771
82. Stl559050
83. Zinc95911093
84. Akos015895184
85. Akos037515521
86. Cs-7724
87. Ks-5297
88. Idi1_002098
89. Qtl1_000044
90. Ncgc00094565-01
91. Ncgc00094565-02
92. Ncgc00094565-03
93. Ncgc00094565-04
94. Ncgc00094565-05
95. Ncgc00179338-01
96. Nci60_001565
97. Db-051705
98. Ft-0603426
99. H0142
100. C09904
101. C75327
102. D04876
103. Beta-thujaplicin, Saj Special Grade, >=99.0%
104. 2-hydroxy-4-isopropyl-2,6-cycloheptatrien-1-one
105. 2-hydroxy-4-isopropyl-cyclohepta-2,4,6-trienone
106. 2-hydroxy-6-isopropyl-2,4,6-cycloheptene-1-one
107. 499h445
108. A923788
109. Sr-01000737397
110. 2,6-cycloheptatrien-1-one, 2-hydroxy-4-isopropyl-
111. 2-hydroxy-4-isopropyl-cyclohepta2,4,6-trien-1-one
112. J-521461
113. Q2705171
114. Sr-01000737397-2
115. 2-hydroxy-4-isopropyl-2,4, 6-cycloheptatrien-1-one
116. 2-hydroxy-4-isopropyl-cyclohepta-2,4,6-trien-1-one
117. Brd-k37691127-001-02-2
118. 2-hydroxy-6-propan-2-yl-1-cyclohepta-2,4,6-trienone
119. 2-oxidanyl-6-propan-2-yl-cyclohepta-2,4,6-trien-1-one
120. Z2671848059
121. 2,6-cycloheptatrien-1-one, 2-hydroxy-4-(1-methylethyl)-
122. (2e,4z,6z)-2-hydroxy-4-isopropylcyclohepta-2,4,6-trienone
123. 2-hydroxy-4(6)-(1-methylethyl)-2,4,6-cycloheptatrien-1-one, 9ci
Molecular Weight | 164.20 g/mol |
---|---|
Molecular Formula | C10H12O2 |
XLogP3 | 2.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 1 |
Exact Mass | 164.083729621 g/mol |
Monoisotopic Mass | 164.083729621 g/mol |
Topological Polar Surface Area | 37.3 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 280 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
Iron Chelating Agents
Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. (See all compounds classified as Iron Chelating Agents.)
Antineoplastic Agents, Phytogenic
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)
ANALYTICAL
ABOUT THIS PAGE
A Hinokitiol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hinokitiol, including repackagers and relabelers. The FDA regulates Hinokitiol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hinokitiol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hinokitiol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hinokitiol supplier is an individual or a company that provides Hinokitiol active pharmaceutical ingredient (API) or Hinokitiol finished formulations upon request. The Hinokitiol suppliers may include Hinokitiol API manufacturers, exporters, distributors and traders.
click here to find a list of Hinokitiol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Hinokitiol Drug Master File in Japan (Hinokitiol JDMF) empowers Hinokitiol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Hinokitiol JDMF during the approval evaluation for pharmaceutical products. At the time of Hinokitiol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Hinokitiol suppliers with JDMF on PharmaCompass.
Hinokitiol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hinokitiol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hinokitiol GMP manufacturer or Hinokitiol GMP API supplier for your needs.
A Hinokitiol CoA (Certificate of Analysis) is a formal document that attests to Hinokitiol's compliance with Hinokitiol specifications and serves as a tool for batch-level quality control.
Hinokitiol CoA mostly includes findings from lab analyses of a specific batch. For each Hinokitiol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hinokitiol may be tested according to a variety of international standards, such as European Pharmacopoeia (Hinokitiol EP), Hinokitiol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hinokitiol USP).
LOOKING FOR A SUPPLIER?